« Back
Home /
Girentuximab

Girentuximab

Manufacturer	MedChem Express
Category	Antibodies In Vivo Antibodies
Type	Biosimilars
Specific against	other
Amount	10 mg
Item no.	HY-P99023-10mg
CASRN	916138-87-9
eClass 6.1	32160702
eClass 9.0	42030590
Available
Product Description	Girentuximab (G250) is a chimeric monoclonal antibody that binds carbonic anhydrase IX (CAIX), a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC)[1].
StorageTemperature	Store at -80°C for 2 years
Shipping	Dry Ice
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	N/A
Clinical_Information	Phase 3
Manufacturers Research_Area	Cancer
Solubility	H2O
Manufacturers Target	Carbonic Anhydrase
Isoform	CA Ⅸ
Pathway	Metabolic Enzyme/Protease
Manufacturers Product type	Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10 mg

available

Request delivery time